Home

Cymbalta

Cymbalta is the brand name for duloxetine, a prescription serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat certain mood disorders and chronic pain conditions. In the United States, duloxetine is approved for major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain (such as osteoarthritis or low back pain). The drug is available as oral capsules.

Mechanism and pharmacology: Duloxetine increases the levels of the neurotransmitters serotonin and norepinephrine in the central

Dosing and administration: Starting and target doses vary by condition. Commonly, for major depressive disorder and

Safety and interactions: Duloxetine may cause nausea, dry mouth, fatigue, insomnia or sleep disturbance, dizziness, reduced

Brand and generic status: Cymbalta is the brand name; duloxetine is available as a generic medication.

nervous
system
by
inhibiting
their
reuptake
into
presynaptic
neurons.
It
also
has
weak
dopaminergic
effects
at
higher
doses.
Duloxetine
is
metabolized
mainly
in
the
liver
by
the
enzymes
CYP1A2
and
CYP2D6,
and
it
is
a
moderate
inhibitor
of
CYP2D6,
which
can
affect
the
metabolism
of
other
drugs.
The
elimination
half-life
is
typically
around
12
hours,
and
a
steady
state
is
reached
within
several
days.
About
half
to
two-thirds
of
a
dose
is
excreted
in
the
urine.
generalized
anxiety
disorder,
starting
at
40
mg
once
daily
with
gradual
increases
up
to
a
usual
maximum
of
120
mg
daily.
For
diabetic
neuropathy,
fibromyalgia,
and
chronic
musculoskeletal
pain,
starting
doses
of
30–60
mg
daily
may
be
used,
with
gradual
titration
up
to
60–120
mg
daily.
Duloxetine
can
be
given
once
daily;
if
dosing
above
60
mg,
some
regimens
use
once-daily
dosing.
Dose
adjustments
are
slower
in
older
adults
or
those
with
liver
impairment.
appetite,
and
sexual
dysfunction.
It
can
raise
blood
pressure
and
interact
with
other
serotonergic
drugs,
increasing
the
risk
of
serotonin
syndrome.
Discontinuation
should
be
gradual
to
limit
withdrawal
symptoms.
Contraindications
include
concurrent
monoamine
oxidase
inhibitors
and
hypersensitivity.
Caution
is
advised
in
liver
disease,
substantial
alcohol
use,
glaucoma,
and
elderly
patients.
Pregnancy
category
C;
duloxetine
passes
into
breast
milk.